Global Sepsis Rapid Diagnosis Market Growth (Status and Outlook) 2026-2032
The global Sepsis Rapid Diagnosis market size is predicted to grow from US$ 623 million in 2025 to US$ 1247 million in 2032; it is expected to grow at a CAGR of 10.6% from 2026 to 2032.
Sepsis rapid diagnosis refers to the class of in vitro diagnostic technologies and systems designed to identify bloodstream infection or the host’s dysregulated inflammatory response in the shortest possible time within emergency and critical-care settings. This category includes direct-from-blood molecular assays, rapid blood-culture and organism-identification platforms, multiplex nucleic-acid pathogen panels, host-response/biomarker rapid immunoassays, and integrated point-of-care or fast-laboratory workflows. Its core value lies in shrinking time-to-diagnosis from days to hours or minutes, thereby enabling immediate antimicrobial decision-making, risk stratification, and critical-care interventions—improving outcomes and lowering inpatient costs.
Sepsis rapid diagnostics are at an inflection point moving from “technical feasibility” toward “clinical and procurement standardization.” Policy emphasis by governments and international health bodies on early recognition and rapid intervention creates a policy-backed entry for diagnostics with clinical evidence; meanwhile, multiple public diagnostic companies cite rapid molecular and host-response testing as priority growth areas in their annual reports, indicating continued capital and R&D allocation. Hospital demand for shorter decision times, optimized antimicrobial use and improved critical-care outcomes drives procurement away from single-use reagents toward integrated “reagents–platform–digital” solutions. Sell-side and industry research widely note that products delivering immediate, clinically actionable results while addressing cost-effectiveness will be prioritized in large health-system tenders. Despite clear opportunities, the commercialization pathway for rapid diagnostics faces regulatory and implementation challenges. Divergent regulatory, reimbursement, and compliance frameworks across markets require early multi-market registration strategies—an issue highlighted in corporate annual reports. Clinical evidence generation and real-world implementation studies are critical adoption gates. Moreover, the stability of upstream reagents and disposables, interoperability with laboratory informatics, and the ability to embed devices into clinical pathways materially affect rollout speed and customer satisfaction; weaknesses in any component can substantially delay hospital-scale deployment. Healthcare customers demonstrate a concurrent demand for speed, actionability, and integrated services: EDs and ICUs prioritize minute-to-hour diagnostics, elevating POC and rapid molecular tests into core emergency workflows; antimicrobial stewardship and infection-control teams expect test results to directly trigger antimicrobial start/stop and stratified treatment, raising requirements for report interpretation and decision-support. Governmental and hospital quality programs—evidenced in annual reports and public guidance—are increasingly incorporating sepsis testing into institutional quality metrics and procurement priorities, shifting buyer evaluation from price-only to a comprehensive assessment of clinical value and implementation services. The upstream supply base for sepsis rapid diagnostics includes high-grade reagent enzymes and nucleic-acid extraction kits, disposable microfluidic cartridges or chips, capture/label antibodies and lateral-flow materials, and the sensitive electronics and software modules required by platforms. Annual reports indicate reagents and single-use consumables are margin drivers and scaling levers; localizing and diversifying supply chains directly impacts tender competitiveness and delivery timelines. Platform vendors also emphasize sustained investment in hardware–software integration and data analytics (including AI), implying that upstream investment extends beyond raw materials into proprietary processes and digital capabilities—core sources of future differentiation and a durable moat for incumbents.
This Insight Report provides a comprehensive analysis of the global Sepsis Rapid Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sepsis Rapid Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sepsis Rapid Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sepsis Rapid Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sepsis Rapid Diagnosis.
This report presents a comprehensive overview, market shares, and growth opportunities of Sepsis Rapid Diagnosis market by product type, application, key players and key regions and countries.
Sepsis rapid diagnosis refers to the class of in vitro diagnostic technologies and systems designed to identify bloodstream infection or the host’s dysregulated inflammatory response in the shortest possible time within emergency and critical-care settings. This category includes direct-from-blood molecular assays, rapid blood-culture and organism-identification platforms, multiplex nucleic-acid pathogen panels, host-response/biomarker rapid immunoassays, and integrated point-of-care or fast-laboratory workflows. Its core value lies in shrinking time-to-diagnosis from days to hours or minutes, thereby enabling immediate antimicrobial decision-making, risk stratification, and critical-care interventions—improving outcomes and lowering inpatient costs.
Sepsis rapid diagnostics are at an inflection point moving from “technical feasibility” toward “clinical and procurement standardization.” Policy emphasis by governments and international health bodies on early recognition and rapid intervention creates a policy-backed entry for diagnostics with clinical evidence; meanwhile, multiple public diagnostic companies cite rapid molecular and host-response testing as priority growth areas in their annual reports, indicating continued capital and R&D allocation. Hospital demand for shorter decision times, optimized antimicrobial use and improved critical-care outcomes drives procurement away from single-use reagents toward integrated “reagents–platform–digital” solutions. Sell-side and industry research widely note that products delivering immediate, clinically actionable results while addressing cost-effectiveness will be prioritized in large health-system tenders. Despite clear opportunities, the commercialization pathway for rapid diagnostics faces regulatory and implementation challenges. Divergent regulatory, reimbursement, and compliance frameworks across markets require early multi-market registration strategies—an issue highlighted in corporate annual reports. Clinical evidence generation and real-world implementation studies are critical adoption gates. Moreover, the stability of upstream reagents and disposables, interoperability with laboratory informatics, and the ability to embed devices into clinical pathways materially affect rollout speed and customer satisfaction; weaknesses in any component can substantially delay hospital-scale deployment. Healthcare customers demonstrate a concurrent demand for speed, actionability, and integrated services: EDs and ICUs prioritize minute-to-hour diagnostics, elevating POC and rapid molecular tests into core emergency workflows; antimicrobial stewardship and infection-control teams expect test results to directly trigger antimicrobial start/stop and stratified treatment, raising requirements for report interpretation and decision-support. Governmental and hospital quality programs—evidenced in annual reports and public guidance—are increasingly incorporating sepsis testing into institutional quality metrics and procurement priorities, shifting buyer evaluation from price-only to a comprehensive assessment of clinical value and implementation services. The upstream supply base for sepsis rapid diagnostics includes high-grade reagent enzymes and nucleic-acid extraction kits, disposable microfluidic cartridges or chips, capture/label antibodies and lateral-flow materials, and the sensitive electronics and software modules required by platforms. Annual reports indicate reagents and single-use consumables are margin drivers and scaling levers; localizing and diversifying supply chains directly impacts tender competitiveness and delivery timelines. Platform vendors also emphasize sustained investment in hardware–software integration and data analytics (including AI), implying that upstream investment extends beyond raw materials into proprietary processes and digital capabilities—core sources of future differentiation and a durable moat for incumbents.
Report Scope
LPI (LP Information)' newest research report, the “Sepsis Rapid Diagnosis Industry Forecast” looks at past sales and reviews total world Sepsis Rapid Diagnosis sales in 2025, providing a comprehensive analysis by region and market sector of projected Sepsis Rapid Diagnosis sales for 2026 through 2032. With Sepsis Rapid Diagnosis sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Sepsis Rapid Diagnosis industry.This Insight Report provides a comprehensive analysis of the global Sepsis Rapid Diagnosis landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Sepsis Rapid Diagnosis portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Sepsis Rapid Diagnosis market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Sepsis Rapid Diagnosis and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Sepsis Rapid Diagnosis.
This report presents a comprehensive overview, market shares, and growth opportunities of Sepsis Rapid Diagnosis market by product type, application, key players and key regions and countries.
Market Segmentation
Segmentation by Type:
- Blood Culture
- Molecular Testing
- Bacterial Examination
- Other
Segmentation by Application:
- Hospital
- Third-party Laboratory
- Other
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- BD
- Thermo Fisher Scientific
- bioM?rieux
- Danaher
- Roche
- QuantaMatrix
- Abbott Laboratories
- T2 Biosystems
- Immunexpress
- Qiagen
- Response Biomedical
- Mindray
- Siemens Healthineers
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sepsis Rapid Diagnosis Market Size (2021-2032)
2.1.2 Sepsis Rapid Diagnosis Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Sepsis Rapid Diagnosis by Country/Region (2021, 2025 & 2032)
2.2 Sepsis Rapid Diagnosis Segment by Type
2.2.1 Blood Culture
2.2.2 Molecular Testing
2.2.3 Bacterial Examination
2.2.4 Other
2.2.5 Sepsis Rapid Diagnosis Market Size by Type
2.2.5.1 Sepsis Rapid Diagnosis Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Sepsis Rapid Diagnosis Market Size Market Share by Type (2021-2026)
2.3 Sepsis Rapid Diagnosis Segment by Application
2.3.1 Hospital
2.3.2 Third-party Laboratory
2.3.3 Other
2.3.4 Sepsis Rapid Diagnosis Market Size by Application
2.3.4.1 Sepsis Rapid Diagnosis Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Sepsis Rapid Diagnosis Market Size Market Share by Application (2021-2026)
3 SEPSIS RAPID DIAGNOSIS MARKET SIZE BY PLAYER
3.1 Sepsis Rapid Diagnosis Market Size Market Share by Player
3.1.1 Global Sepsis Rapid Diagnosis Revenue by Player (2021-2026)
3.1.2 Global Sepsis Rapid Diagnosis Revenue Market Share by Player (2021-2026)
3.2 Global Sepsis Rapid Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SEPSIS RAPID DIAGNOSIS BY REGION
4.1 Sepsis Rapid Diagnosis Market Size by Region (2021-2026)
4.2 Global Sepsis Rapid Diagnosis Annual Revenue by Country/Region (2021-2026)
4.3 Americas Sepsis Rapid Diagnosis Market Size Growth (2021-2026)
4.4 APAC Sepsis Rapid Diagnosis Market Size Growth (2021-2026)
4.5 Europe Sepsis Rapid Diagnosis Market Size Growth (2021-2026)
4.6 Middle East & Africa Sepsis Rapid Diagnosis Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Sepsis Rapid Diagnosis Market Size by Country (2021-2026)
5.2 Americas Sepsis Rapid Diagnosis Market Size by Type (2021-2026)
5.3 Americas Sepsis Rapid Diagnosis Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sepsis Rapid Diagnosis Market Size by Region (2021-2026)
6.2 APAC Sepsis Rapid Diagnosis Market Size by Type (2021-2026)
6.3 APAC Sepsis Rapid Diagnosis Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sepsis Rapid Diagnosis Market Size by Country (2021-2026)
7.2 Europe Sepsis Rapid Diagnosis Market Size by Type (2021-2026)
7.3 Europe Sepsis Rapid Diagnosis Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sepsis Rapid Diagnosis by Region (2021-2026)
8.2 Middle East & Africa Sepsis Rapid Diagnosis Market Size by Type (2021-2026)
8.3 Middle East & Africa Sepsis Rapid Diagnosis Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SEPSIS RAPID DIAGNOSIS MARKET FORECAST
10.1 Global Sepsis Rapid Diagnosis Forecast by Region (2027-2032)
10.1.1 Global Sepsis Rapid Diagnosis Forecast by Region (2027-2032)
10.1.2 Americas Sepsis Rapid Diagnosis Forecast
10.1.3 APAC Sepsis Rapid Diagnosis Forecast
10.1.4 Europe Sepsis Rapid Diagnosis Forecast
10.1.5 Middle East & Africa Sepsis Rapid Diagnosis Forecast
10.2 Americas Sepsis Rapid Diagnosis Forecast by Country (2027-2032)
10.2.1 United States Market Sepsis Rapid Diagnosis Forecast
10.2.2 Canada Market Sepsis Rapid Diagnosis Forecast
10.2.3 Mexico Market Sepsis Rapid Diagnosis Forecast
10.2.4 Brazil Market Sepsis Rapid Diagnosis Forecast
10.3 APAC Sepsis Rapid Diagnosis Forecast by Region (2027-2032)
10.3.1 China Sepsis Rapid Diagnosis Market Forecast
10.3.2 Japan Market Sepsis Rapid Diagnosis Forecast
10.3.3 Korea Market Sepsis Rapid Diagnosis Forecast
10.3.4 Southeast Asia Market Sepsis Rapid Diagnosis Forecast
10.3.5 India Market Sepsis Rapid Diagnosis Forecast
10.3.6 Australia Market Sepsis Rapid Diagnosis Forecast
10.4 Europe Sepsis Rapid Diagnosis Forecast by Country (2027-2032)
10.4.1 Germany Market Sepsis Rapid Diagnosis Forecast
10.4.2 France Market Sepsis Rapid Diagnosis Forecast
10.4.3 UK Market Sepsis Rapid Diagnosis Forecast
10.4.4 Italy Market Sepsis Rapid Diagnosis Forecast
10.4.5 Russia Market Sepsis Rapid Diagnosis Forecast
10.5 Middle East & Africa Sepsis Rapid Diagnosis Forecast by Region (2027-2032)
10.5.1 Egypt Market Sepsis Rapid Diagnosis Forecast
10.5.2 South Africa Market Sepsis Rapid Diagnosis Forecast
10.5.3 Israel Market Sepsis Rapid Diagnosis Forecast
10.5.4 Turkey Market Sepsis Rapid Diagnosis Forecast
10.6 Global Sepsis Rapid Diagnosis Forecast by Type (2027-2032)
10.7 Global Sepsis Rapid Diagnosis Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Sepsis Rapid Diagnosis Forecast
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Sepsis Rapid Diagnosis Product Offered
11.1.3 BD Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Sepsis Rapid Diagnosis Product Offered
11.2.3 Thermo Fisher Scientific Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 bioM?rieux
11.3.1 bioM?rieux Company Information
11.3.2 bioM?rieux Sepsis Rapid Diagnosis Product Offered
11.3.3 bioM?rieux Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 bioM?rieux Main Business Overview
11.3.5 bioM?rieux Latest Developments
11.4 Danaher
11.4.1 Danaher Company Information
11.4.2 Danaher Sepsis Rapid Diagnosis Product Offered
11.4.3 Danaher Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Danaher Main Business Overview
11.4.5 Danaher Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Sepsis Rapid Diagnosis Product Offered
11.5.3 Roche Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 QuantaMatrix
11.6.1 QuantaMatrix Company Information
11.6.2 QuantaMatrix Sepsis Rapid Diagnosis Product Offered
11.6.3 QuantaMatrix Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 QuantaMatrix Main Business Overview
11.6.5 QuantaMatrix Latest Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Information
11.7.2 Abbott Laboratories Sepsis Rapid Diagnosis Product Offered
11.7.3 Abbott Laboratories Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Abbott Laboratories Main Business Overview
11.7.5 Abbott Laboratories Latest Developments
11.8 T2 Biosystems
11.8.1 T2 Biosystems Company Information
11.8.2 T2 Biosystems Sepsis Rapid Diagnosis Product Offered
11.8.3 T2 Biosystems Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 T2 Biosystems Main Business Overview
11.8.5 T2 Biosystems Latest Developments
11.9 Immunexpress
11.9.1 Immunexpress Company Information
11.9.2 Immunexpress Sepsis Rapid Diagnosis Product Offered
11.9.3 Immunexpress Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Immunexpress Main Business Overview
11.9.5 Immunexpress Latest Developments
11.10 Qiagen
11.10.1 Qiagen Company Information
11.10.2 Qiagen Sepsis Rapid Diagnosis Product Offered
11.10.3 Qiagen Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Qiagen Main Business Overview
11.10.5 Qiagen Latest Developments
11.11 Response Biomedical
11.11.1 Response Biomedical Company Information
11.11.2 Response Biomedical Sepsis Rapid Diagnosis Product Offered
11.11.3 Response Biomedical Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Response Biomedical Main Business Overview
11.11.5 Response Biomedical Latest Developments
11.12 Mindray
11.12.1 Mindray Company Information
11.12.2 Mindray Sepsis Rapid Diagnosis Product Offered
11.12.3 Mindray Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Mindray Main Business Overview
11.12.5 Mindray Latest Developments
11.13 Siemens Healthineers
11.13.1 Siemens Healthineers Company Information
11.13.2 Siemens Healthineers Sepsis Rapid Diagnosis Product Offered
11.13.3 Siemens Healthineers Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Siemens Healthineers Main Business Overview
11.13.5 Siemens Healthineers Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Sepsis Rapid Diagnosis Market Size (2021-2032)
2.1.2 Sepsis Rapid Diagnosis Market Size CAGR by Region (2021 VS 2025 VS 2032)
2.1.3 World Current & Future Analysis for Sepsis Rapid Diagnosis by Country/Region (2021, 2025 & 2032)
2.2 Sepsis Rapid Diagnosis Segment by Type
2.2.1 Blood Culture
2.2.2 Molecular Testing
2.2.3 Bacterial Examination
2.2.4 Other
2.2.5 Sepsis Rapid Diagnosis Market Size by Type
2.2.5.1 Sepsis Rapid Diagnosis Market Size CAGR by Type (2021 VS 2025 VS 2032)
2.2.5.2 Global Sepsis Rapid Diagnosis Market Size Market Share by Type (2021-2026)
2.3 Sepsis Rapid Diagnosis Segment by Application
2.3.1 Hospital
2.3.2 Third-party Laboratory
2.3.3 Other
2.3.4 Sepsis Rapid Diagnosis Market Size by Application
2.3.4.1 Sepsis Rapid Diagnosis Market Size CAGR by Application (2021 VS 2025 VS 2032)
2.3.4.2 Global Sepsis Rapid Diagnosis Market Size Market Share by Application (2021-2026)
3 SEPSIS RAPID DIAGNOSIS MARKET SIZE BY PLAYER
3.1 Sepsis Rapid Diagnosis Market Size Market Share by Player
3.1.1 Global Sepsis Rapid Diagnosis Revenue by Player (2021-2026)
3.1.2 Global Sepsis Rapid Diagnosis Revenue Market Share by Player (2021-2026)
3.2 Global Sepsis Rapid Diagnosis Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 SEPSIS RAPID DIAGNOSIS BY REGION
4.1 Sepsis Rapid Diagnosis Market Size by Region (2021-2026)
4.2 Global Sepsis Rapid Diagnosis Annual Revenue by Country/Region (2021-2026)
4.3 Americas Sepsis Rapid Diagnosis Market Size Growth (2021-2026)
4.4 APAC Sepsis Rapid Diagnosis Market Size Growth (2021-2026)
4.5 Europe Sepsis Rapid Diagnosis Market Size Growth (2021-2026)
4.6 Middle East & Africa Sepsis Rapid Diagnosis Market Size Growth (2021-2026)
5 AMERICAS
5.1 Americas Sepsis Rapid Diagnosis Market Size by Country (2021-2026)
5.2 Americas Sepsis Rapid Diagnosis Market Size by Type (2021-2026)
5.3 Americas Sepsis Rapid Diagnosis Market Size by Application (2021-2026)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Sepsis Rapid Diagnosis Market Size by Region (2021-2026)
6.2 APAC Sepsis Rapid Diagnosis Market Size by Type (2021-2026)
6.3 APAC Sepsis Rapid Diagnosis Market Size by Application (2021-2026)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Sepsis Rapid Diagnosis Market Size by Country (2021-2026)
7.2 Europe Sepsis Rapid Diagnosis Market Size by Type (2021-2026)
7.3 Europe Sepsis Rapid Diagnosis Market Size by Application (2021-2026)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Sepsis Rapid Diagnosis by Region (2021-2026)
8.2 Middle East & Africa Sepsis Rapid Diagnosis Market Size by Type (2021-2026)
8.3 Middle East & Africa Sepsis Rapid Diagnosis Market Size by Application (2021-2026)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL SEPSIS RAPID DIAGNOSIS MARKET FORECAST
10.1 Global Sepsis Rapid Diagnosis Forecast by Region (2027-2032)
10.1.1 Global Sepsis Rapid Diagnosis Forecast by Region (2027-2032)
10.1.2 Americas Sepsis Rapid Diagnosis Forecast
10.1.3 APAC Sepsis Rapid Diagnosis Forecast
10.1.4 Europe Sepsis Rapid Diagnosis Forecast
10.1.5 Middle East & Africa Sepsis Rapid Diagnosis Forecast
10.2 Americas Sepsis Rapid Diagnosis Forecast by Country (2027-2032)
10.2.1 United States Market Sepsis Rapid Diagnosis Forecast
10.2.2 Canada Market Sepsis Rapid Diagnosis Forecast
10.2.3 Mexico Market Sepsis Rapid Diagnosis Forecast
10.2.4 Brazil Market Sepsis Rapid Diagnosis Forecast
10.3 APAC Sepsis Rapid Diagnosis Forecast by Region (2027-2032)
10.3.1 China Sepsis Rapid Diagnosis Market Forecast
10.3.2 Japan Market Sepsis Rapid Diagnosis Forecast
10.3.3 Korea Market Sepsis Rapid Diagnosis Forecast
10.3.4 Southeast Asia Market Sepsis Rapid Diagnosis Forecast
10.3.5 India Market Sepsis Rapid Diagnosis Forecast
10.3.6 Australia Market Sepsis Rapid Diagnosis Forecast
10.4 Europe Sepsis Rapid Diagnosis Forecast by Country (2027-2032)
10.4.1 Germany Market Sepsis Rapid Diagnosis Forecast
10.4.2 France Market Sepsis Rapid Diagnosis Forecast
10.4.3 UK Market Sepsis Rapid Diagnosis Forecast
10.4.4 Italy Market Sepsis Rapid Diagnosis Forecast
10.4.5 Russia Market Sepsis Rapid Diagnosis Forecast
10.5 Middle East & Africa Sepsis Rapid Diagnosis Forecast by Region (2027-2032)
10.5.1 Egypt Market Sepsis Rapid Diagnosis Forecast
10.5.2 South Africa Market Sepsis Rapid Diagnosis Forecast
10.5.3 Israel Market Sepsis Rapid Diagnosis Forecast
10.5.4 Turkey Market Sepsis Rapid Diagnosis Forecast
10.6 Global Sepsis Rapid Diagnosis Forecast by Type (2027-2032)
10.7 Global Sepsis Rapid Diagnosis Forecast by Application (2027-2032)
10.7.1 GCC Countries Market Sepsis Rapid Diagnosis Forecast
11 KEY PLAYERS ANALYSIS
11.1 BD
11.1.1 BD Company Information
11.1.2 BD Sepsis Rapid Diagnosis Product Offered
11.1.3 BD Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.1.4 BD Main Business Overview
11.1.5 BD Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific Sepsis Rapid Diagnosis Product Offered
11.2.3 Thermo Fisher Scientific Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 bioM?rieux
11.3.1 bioM?rieux Company Information
11.3.2 bioM?rieux Sepsis Rapid Diagnosis Product Offered
11.3.3 bioM?rieux Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.3.4 bioM?rieux Main Business Overview
11.3.5 bioM?rieux Latest Developments
11.4 Danaher
11.4.1 Danaher Company Information
11.4.2 Danaher Sepsis Rapid Diagnosis Product Offered
11.4.3 Danaher Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.4.4 Danaher Main Business Overview
11.4.5 Danaher Latest Developments
11.5 Roche
11.5.1 Roche Company Information
11.5.2 Roche Sepsis Rapid Diagnosis Product Offered
11.5.3 Roche Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.5.4 Roche Main Business Overview
11.5.5 Roche Latest Developments
11.6 QuantaMatrix
11.6.1 QuantaMatrix Company Information
11.6.2 QuantaMatrix Sepsis Rapid Diagnosis Product Offered
11.6.3 QuantaMatrix Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.6.4 QuantaMatrix Main Business Overview
11.6.5 QuantaMatrix Latest Developments
11.7 Abbott Laboratories
11.7.1 Abbott Laboratories Company Information
11.7.2 Abbott Laboratories Sepsis Rapid Diagnosis Product Offered
11.7.3 Abbott Laboratories Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.7.4 Abbott Laboratories Main Business Overview
11.7.5 Abbott Laboratories Latest Developments
11.8 T2 Biosystems
11.8.1 T2 Biosystems Company Information
11.8.2 T2 Biosystems Sepsis Rapid Diagnosis Product Offered
11.8.3 T2 Biosystems Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.8.4 T2 Biosystems Main Business Overview
11.8.5 T2 Biosystems Latest Developments
11.9 Immunexpress
11.9.1 Immunexpress Company Information
11.9.2 Immunexpress Sepsis Rapid Diagnosis Product Offered
11.9.3 Immunexpress Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.9.4 Immunexpress Main Business Overview
11.9.5 Immunexpress Latest Developments
11.10 Qiagen
11.10.1 Qiagen Company Information
11.10.2 Qiagen Sepsis Rapid Diagnosis Product Offered
11.10.3 Qiagen Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.10.4 Qiagen Main Business Overview
11.10.5 Qiagen Latest Developments
11.11 Response Biomedical
11.11.1 Response Biomedical Company Information
11.11.2 Response Biomedical Sepsis Rapid Diagnosis Product Offered
11.11.3 Response Biomedical Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.11.4 Response Biomedical Main Business Overview
11.11.5 Response Biomedical Latest Developments
11.12 Mindray
11.12.1 Mindray Company Information
11.12.2 Mindray Sepsis Rapid Diagnosis Product Offered
11.12.3 Mindray Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.12.4 Mindray Main Business Overview
11.12.5 Mindray Latest Developments
11.13 Siemens Healthineers
11.13.1 Siemens Healthineers Company Information
11.13.2 Siemens Healthineers Sepsis Rapid Diagnosis Product Offered
11.13.3 Siemens Healthineers Sepsis Rapid Diagnosis Revenue, Gross Margin and Market Share (2021-2026)
11.13.4 Siemens Healthineers Main Business Overview
11.13.5 Siemens Healthineers Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Sepsis Rapid Diagnosis Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Sepsis Rapid Diagnosis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Culture
Table 4. Major Players of Molecular Testing
Table 5. Major Players of Bacterial Examination
Table 6. Major Players of Other
Table 7. Sepsis Rapid Diagnosis Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Sepsis Rapid Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Sepsis Rapid Diagnosis Market Size Market Share by Type (2021-2026)
Table 10. Sepsis Rapid Diagnosis Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Sepsis Rapid Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Sepsis Rapid Diagnosis Market Size Market Share by Application (2021-2026)
Table 13. Global Sepsis Rapid Diagnosis Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Sepsis Rapid Diagnosis Revenue Market Share by Player (2021-2026)
Table 15. Sepsis Rapid Diagnosis Key Players Head office and Products Offered
Table 16. Sepsis Rapid Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Sepsis Rapid Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Sepsis Rapid Diagnosis Market Size Market Share by Region (2021-2026)
Table 21. Global Sepsis Rapid Diagnosis Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Sepsis Rapid Diagnosis Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Sepsis Rapid Diagnosis Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Sepsis Rapid Diagnosis Market Size Market Share by Country (2021-2026)
Table 25. Americas Sepsis Rapid Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Sepsis Rapid Diagnosis Market Size Market Share by Type (2021-2026)
Table 27. Americas Sepsis Rapid Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Sepsis Rapid Diagnosis Market Size Market Share by Application (2021-2026)
Table 29. APAC Sepsis Rapid Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Sepsis Rapid Diagnosis Market Size Market Share by Region (2021-2026)
Table 31. APAC Sepsis Rapid Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Sepsis Rapid Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Sepsis Rapid Diagnosis Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Sepsis Rapid Diagnosis Market Size Market Share by Country (2021-2026)
Table 35. Europe Sepsis Rapid Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Sepsis Rapid Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Sepsis Rapid Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Sepsis Rapid Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Sepsis Rapid Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Sepsis Rapid Diagnosis
Table 41. Key Market Challenges & Risks of Sepsis Rapid Diagnosis
Table 42. Key Industry Trends of Sepsis Rapid Diagnosis
Table 43. Global Sepsis Rapid Diagnosis Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Sepsis Rapid Diagnosis Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Sepsis Rapid Diagnosis Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Sepsis Rapid Diagnosis Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. BD Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 48. BD Sepsis Rapid Diagnosis Product Offered
Table 49. BD Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. BD Main Business
Table 51. BD Latest Developments
Table 52. Thermo Fisher Scientific Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 53. Thermo Fisher Scientific Sepsis Rapid Diagnosis Product Offered
Table 54. Thermo Fisher Scientific Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Thermo Fisher Scientific Main Business
Table 56. Thermo Fisher Scientific Latest Developments
Table 57. bioM?rieux Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 58. bioM?rieux Sepsis Rapid Diagnosis Product Offered
Table 59. bioM?rieux Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. bioM?rieux Main Business
Table 61. bioM?rieux Latest Developments
Table 62. Danaher Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 63. Danaher Sepsis Rapid Diagnosis Product Offered
Table 64. Danaher Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Danaher Main Business
Table 66. Danaher Latest Developments
Table 67. Roche Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 68. Roche Sepsis Rapid Diagnosis Product Offered
Table 69. Roche Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Roche Main Business
Table 71. Roche Latest Developments
Table 72. QuantaMatrix Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 73. QuantaMatrix Sepsis Rapid Diagnosis Product Offered
Table 74. QuantaMatrix Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. QuantaMatrix Main Business
Table 76. QuantaMatrix Latest Developments
Table 77. Abbott Laboratories Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 78. Abbott Laboratories Sepsis Rapid Diagnosis Product Offered
Table 79. Abbott Laboratories Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Abbott Laboratories Main Business
Table 81. Abbott Laboratories Latest Developments
Table 82. T2 Biosystems Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 83. T2 Biosystems Sepsis Rapid Diagnosis Product Offered
Table 84. T2 Biosystems Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. T2 Biosystems Main Business
Table 86. T2 Biosystems Latest Developments
Table 87. Immunexpress Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 88. Immunexpress Sepsis Rapid Diagnosis Product Offered
Table 89. Immunexpress Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Immunexpress Main Business
Table 91. Immunexpress Latest Developments
Table 92. Qiagen Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 93. Qiagen Sepsis Rapid Diagnosis Product Offered
Table 94. Qiagen Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Qiagen Main Business
Table 96. Qiagen Latest Developments
Table 97. Response Biomedical Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 98. Response Biomedical Sepsis Rapid Diagnosis Product Offered
Table 99. Response Biomedical Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Response Biomedical Main Business
Table 101. Response Biomedical Latest Developments
Table 102. Mindray Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 103. Mindray Sepsis Rapid Diagnosis Product Offered
Table 104. Mindray Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Mindray Main Business
Table 106. Mindray Latest Developments
Table 107. Siemens Healthineers Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 108. Siemens Healthineers Sepsis Rapid Diagnosis Product Offered
Table 109. Siemens Healthineers Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Siemens Healthineers Main Business
Table 111. Siemens Healthineers Latest Developments
Table 1. Sepsis Rapid Diagnosis Market Size CAGR by Region (2021 VS 2025 VS 2032) & ($ millions)
Table 2. Sepsis Rapid Diagnosis Annual Sales CAGR by Country/Region (2021, 2025 & 2032) & ($ millions)
Table 3. Major Players of Blood Culture
Table 4. Major Players of Molecular Testing
Table 5. Major Players of Bacterial Examination
Table 6. Major Players of Other
Table 7. Sepsis Rapid Diagnosis Market Size CAGR by Type (2021 VS 2025 VS 2032) & ($ millions)
Table 8. Global Sepsis Rapid Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 9. Global Sepsis Rapid Diagnosis Market Size Market Share by Type (2021-2026)
Table 10. Sepsis Rapid Diagnosis Market Size CAGR by Application (2021 VS 2025 VS 2032) & ($ millions)
Table 11. Global Sepsis Rapid Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 12. Global Sepsis Rapid Diagnosis Market Size Market Share by Application (2021-2026)
Table 13. Global Sepsis Rapid Diagnosis Revenue by Player (2021-2026) & ($ millions)
Table 14. Global Sepsis Rapid Diagnosis Revenue Market Share by Player (2021-2026)
Table 15. Sepsis Rapid Diagnosis Key Players Head office and Products Offered
Table 16. Sepsis Rapid Diagnosis Concentration Ratio (CR3, CR5 and CR10) & (2024-2026)
Table 17. New Products and Potential Entrants
Table 18. Mergers & Acquisitions, Expansion
Table 19. Global Sepsis Rapid Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 20. Global Sepsis Rapid Diagnosis Market Size Market Share by Region (2021-2026)
Table 21. Global Sepsis Rapid Diagnosis Revenue by Country/Region (2021-2026) & ($ millions)
Table 22. Global Sepsis Rapid Diagnosis Revenue Market Share by Country/Region (2021-2026)
Table 23. Americas Sepsis Rapid Diagnosis Market Size by Country (2021-2026) & ($ millions)
Table 24. Americas Sepsis Rapid Diagnosis Market Size Market Share by Country (2021-2026)
Table 25. Americas Sepsis Rapid Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 26. Americas Sepsis Rapid Diagnosis Market Size Market Share by Type (2021-2026)
Table 27. Americas Sepsis Rapid Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 28. Americas Sepsis Rapid Diagnosis Market Size Market Share by Application (2021-2026)
Table 29. APAC Sepsis Rapid Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 30. APAC Sepsis Rapid Diagnosis Market Size Market Share by Region (2021-2026)
Table 31. APAC Sepsis Rapid Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 32. APAC Sepsis Rapid Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 33. Europe Sepsis Rapid Diagnosis Market Size by Country (2021-2026) & ($ millions)
Table 34. Europe Sepsis Rapid Diagnosis Market Size Market Share by Country (2021-2026)
Table 35. Europe Sepsis Rapid Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 36. Europe Sepsis Rapid Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 37. Middle East & Africa Sepsis Rapid Diagnosis Market Size by Region (2021-2026) & ($ millions)
Table 38. Middle East & Africa Sepsis Rapid Diagnosis Market Size by Type (2021-2026) & ($ millions)
Table 39. Middle East & Africa Sepsis Rapid Diagnosis Market Size by Application (2021-2026) & ($ millions)
Table 40. Key Market Drivers & Growth Opportunities of Sepsis Rapid Diagnosis
Table 41. Key Market Challenges & Risks of Sepsis Rapid Diagnosis
Table 42. Key Industry Trends of Sepsis Rapid Diagnosis
Table 43. Global Sepsis Rapid Diagnosis Market Size Forecast by Region (2027-2032) & ($ millions)
Table 44. Global Sepsis Rapid Diagnosis Market Size Market Share Forecast by Region (2027-2032)
Table 45. Global Sepsis Rapid Diagnosis Market Size Forecast by Type (2027-2032) & ($ millions)
Table 46. Global Sepsis Rapid Diagnosis Market Size Forecast by Application (2027-2032) & ($ millions)
Table 47. BD Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 48. BD Sepsis Rapid Diagnosis Product Offered
Table 49. BD Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 50. BD Main Business
Table 51. BD Latest Developments
Table 52. Thermo Fisher Scientific Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 53. Thermo Fisher Scientific Sepsis Rapid Diagnosis Product Offered
Table 54. Thermo Fisher Scientific Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 55. Thermo Fisher Scientific Main Business
Table 56. Thermo Fisher Scientific Latest Developments
Table 57. bioM?rieux Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 58. bioM?rieux Sepsis Rapid Diagnosis Product Offered
Table 59. bioM?rieux Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 60. bioM?rieux Main Business
Table 61. bioM?rieux Latest Developments
Table 62. Danaher Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 63. Danaher Sepsis Rapid Diagnosis Product Offered
Table 64. Danaher Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 65. Danaher Main Business
Table 66. Danaher Latest Developments
Table 67. Roche Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 68. Roche Sepsis Rapid Diagnosis Product Offered
Table 69. Roche Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 70. Roche Main Business
Table 71. Roche Latest Developments
Table 72. QuantaMatrix Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 73. QuantaMatrix Sepsis Rapid Diagnosis Product Offered
Table 74. QuantaMatrix Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 75. QuantaMatrix Main Business
Table 76. QuantaMatrix Latest Developments
Table 77. Abbott Laboratories Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 78. Abbott Laboratories Sepsis Rapid Diagnosis Product Offered
Table 79. Abbott Laboratories Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 80. Abbott Laboratories Main Business
Table 81. Abbott Laboratories Latest Developments
Table 82. T2 Biosystems Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 83. T2 Biosystems Sepsis Rapid Diagnosis Product Offered
Table 84. T2 Biosystems Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 85. T2 Biosystems Main Business
Table 86. T2 Biosystems Latest Developments
Table 87. Immunexpress Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 88. Immunexpress Sepsis Rapid Diagnosis Product Offered
Table 89. Immunexpress Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 90. Immunexpress Main Business
Table 91. Immunexpress Latest Developments
Table 92. Qiagen Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 93. Qiagen Sepsis Rapid Diagnosis Product Offered
Table 94. Qiagen Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 95. Qiagen Main Business
Table 96. Qiagen Latest Developments
Table 97. Response Biomedical Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 98. Response Biomedical Sepsis Rapid Diagnosis Product Offered
Table 99. Response Biomedical Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 100. Response Biomedical Main Business
Table 101. Response Biomedical Latest Developments
Table 102. Mindray Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 103. Mindray Sepsis Rapid Diagnosis Product Offered
Table 104. Mindray Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 105. Mindray Main Business
Table 106. Mindray Latest Developments
Table 107. Siemens Healthineers Details, Company Type, Sepsis Rapid Diagnosis Area Served and Its Competitors
Table 108. Siemens Healthineers Sepsis Rapid Diagnosis Product Offered
Table 109. Siemens Healthineers Sepsis Rapid Diagnosis Revenue ($ million), Gross Margin and Market Share (2021-2026)
Table 110. Siemens Healthineers Main Business
Table 111. Siemens Healthineers Latest Developments
LIST OF FIGURES
Figure 1. Sepsis Rapid Diagnosis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sepsis Rapid Diagnosis Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Sepsis Rapid Diagnosis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Sepsis Rapid Diagnosis Sales Market Share by Country/Region (2025)
Figure 8. Sepsis Rapid Diagnosis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Sepsis Rapid Diagnosis Market Size Market Share by Type in 2025
Figure 10. Sepsis Rapid Diagnosis in Hospital
Figure 11. Global Sepsis Rapid Diagnosis Market: Hospital (2021-2026) & ($ millions)
Figure 12. Sepsis Rapid Diagnosis in Third-party Laboratory
Figure 13. Global Sepsis Rapid Diagnosis Market: Third-party Laboratory (2021-2026) & ($ millions)
Figure 14. Sepsis Rapid Diagnosis in Other
Figure 15. Global Sepsis Rapid Diagnosis Market: Other (2021-2026) & ($ millions)
Figure 16. Global Sepsis Rapid Diagnosis Market Size Market Share by Application in 2025
Figure 17. Global Sepsis Rapid Diagnosis Revenue Market Share by Player in 2025
Figure 18. Global Sepsis Rapid Diagnosis Market Size Market Share by Region (2021-2026)
Figure 19. Americas Sepsis Rapid Diagnosis Market Size 2021-2026 ($ millions)
Figure 20. APAC Sepsis Rapid Diagnosis Market Size 2021-2026 ($ millions)
Figure 21. Europe Sepsis Rapid Diagnosis Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Sepsis Rapid Diagnosis Market Size 2021-2026 ($ millions)
Figure 23. Americas Sepsis Rapid Diagnosis Value Market Share by Country in 2025
Figure 24. United States Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Sepsis Rapid Diagnosis Market Size Market Share by Region in 2025
Figure 29. APAC Sepsis Rapid Diagnosis Market Size Market Share by Type (2021-2026)
Figure 30. APAC Sepsis Rapid Diagnosis Market Size Market Share by Application (2021-2026)
Figure 31. China Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 35. India Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Sepsis Rapid Diagnosis Market Size Market Share by Country in 2025
Figure 38. Europe Sepsis Rapid Diagnosis Market Size Market Share by Type (2021-2026)
Figure 39. Europe Sepsis Rapid Diagnosis Market Size Market Share by Application (2021-2026)
Figure 40. Germany Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 41. France Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Sepsis Rapid Diagnosis Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Sepsis Rapid Diagnosis Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Sepsis Rapid Diagnosis Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 54. APAC Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 55. Europe Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 57. United States Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 58. Canada Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 59. Mexico Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 60. Brazil Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 61. China Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 62. Japan Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 63. Korea Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 65. India Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 66. Australia Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 67. Germany Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 68. France Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 69. UK Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 70. Italy Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 71. Russia Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 72. Egypt Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 73. South Africa Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 74. Israel Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 75. Turkey Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 76. Global Sepsis Rapid Diagnosis Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Sepsis Rapid Diagnosis Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 1. Sepsis Rapid Diagnosis Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Sepsis Rapid Diagnosis Market Size Growth Rate (2021-2032) ($ millions)
Figure 6. Sepsis Rapid Diagnosis Sales by Geographic Region (2021, 2025 & 2032) & ($ millions)
Figure 7. Sepsis Rapid Diagnosis Sales Market Share by Country/Region (2025)
Figure 8. Sepsis Rapid Diagnosis Sales Market Share by Country/Region (2021, 2025 & 2032)
Figure 9. Global Sepsis Rapid Diagnosis Market Size Market Share by Type in 2025
Figure 10. Sepsis Rapid Diagnosis in Hospital
Figure 11. Global Sepsis Rapid Diagnosis Market: Hospital (2021-2026) & ($ millions)
Figure 12. Sepsis Rapid Diagnosis in Third-party Laboratory
Figure 13. Global Sepsis Rapid Diagnosis Market: Third-party Laboratory (2021-2026) & ($ millions)
Figure 14. Sepsis Rapid Diagnosis in Other
Figure 15. Global Sepsis Rapid Diagnosis Market: Other (2021-2026) & ($ millions)
Figure 16. Global Sepsis Rapid Diagnosis Market Size Market Share by Application in 2025
Figure 17. Global Sepsis Rapid Diagnosis Revenue Market Share by Player in 2025
Figure 18. Global Sepsis Rapid Diagnosis Market Size Market Share by Region (2021-2026)
Figure 19. Americas Sepsis Rapid Diagnosis Market Size 2021-2026 ($ millions)
Figure 20. APAC Sepsis Rapid Diagnosis Market Size 2021-2026 ($ millions)
Figure 21. Europe Sepsis Rapid Diagnosis Market Size 2021-2026 ($ millions)
Figure 22. Middle East & Africa Sepsis Rapid Diagnosis Market Size 2021-2026 ($ millions)
Figure 23. Americas Sepsis Rapid Diagnosis Value Market Share by Country in 2025
Figure 24. United States Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 25. Canada Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 26. Mexico Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 27. Brazil Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 28. APAC Sepsis Rapid Diagnosis Market Size Market Share by Region in 2025
Figure 29. APAC Sepsis Rapid Diagnosis Market Size Market Share by Type (2021-2026)
Figure 30. APAC Sepsis Rapid Diagnosis Market Size Market Share by Application (2021-2026)
Figure 31. China Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 32. Japan Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 33. South Korea Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 34. Southeast Asia Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 35. India Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 36. Australia Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 37. Europe Sepsis Rapid Diagnosis Market Size Market Share by Country in 2025
Figure 38. Europe Sepsis Rapid Diagnosis Market Size Market Share by Type (2021-2026)
Figure 39. Europe Sepsis Rapid Diagnosis Market Size Market Share by Application (2021-2026)
Figure 40. Germany Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 41. France Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 42. UK Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 43. Italy Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 44. Russia Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 45. Middle East & Africa Sepsis Rapid Diagnosis Market Size Market Share by Region (2021-2026)
Figure 46. Middle East & Africa Sepsis Rapid Diagnosis Market Size Market Share by Type (2021-2026)
Figure 47. Middle East & Africa Sepsis Rapid Diagnosis Market Size Market Share by Application (2021-2026)
Figure 48. Egypt Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 49. South Africa Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 50. Israel Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 51. Turkey Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 52. GCC Countries Sepsis Rapid Diagnosis Market Size Growth 2021-2026 ($ millions)
Figure 53. Americas Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 54. APAC Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 55. Europe Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 56. Middle East & Africa Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 57. United States Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 58. Canada Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 59. Mexico Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 60. Brazil Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 61. China Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 62. Japan Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 63. Korea Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 64. Southeast Asia Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 65. India Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 66. Australia Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 67. Germany Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 68. France Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 69. UK Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 70. Italy Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 71. Russia Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 72. Egypt Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 73. South Africa Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 74. Israel Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 75. Turkey Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
Figure 76. Global Sepsis Rapid Diagnosis Market Size Market Share Forecast by Type (2027-2032)
Figure 77. Global Sepsis Rapid Diagnosis Market Size Market Share Forecast by Application (2027-2032)
Figure 78. GCC Countries Sepsis Rapid Diagnosis Market Size 2027-2032 ($ millions)
